A rigorous multi-laboratory study of known PDAC biomarkers identifies increased sensitivity and specificity over CA19-9 alone

Authors:

Abstract
No abstract available
All Related Versions
Funding Information
  • The University of Texas MD Anderson Cancer Center Sheikh Khalifa Bin Zayed Al Nahyan Institute for Personalized Cancer Therapy
  • National Cancer Institute Division of Cancer Prevention

This publication has 27 references indexed in Scilit: